Global Neuroblastoma Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Neuroblastoma Treatment market size was valued at USD 456.9 million in 2023 and is forecast to a readjusted size of USD 575.4 million by 2030 with a CAGR of 3.3% during review period.
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The market for neuroblastoma treatment is driven by the need for effective and personalized therapies to improve survival rates and long-term outcomes for pediatric cancer patients. The market's growth is also influenced by ongoing research in neuroblastoma therapeutics and the development of targeted and immunotherapeutic approaches.
The Global Info Research report includes an overview of the development of the Neuroblastoma Treatment industry chain, the market status of Hospitals (Combination Chemotherapy, Monoclonal Antibody Therapy), Clinics (Combination Chemotherapy, Monoclonal Antibody Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neuroblastoma Treatment.
Regionally, the report analyzes the Neuroblastoma Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neuroblastoma Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Neuroblastoma Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neuroblastoma Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Combination Chemotherapy, Monoclonal Antibody Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neuroblastoma Treatment market.
Regional Analysis: The report involves examining the Neuroblastoma Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neuroblastoma Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Neuroblastoma Treatment:
Company Analysis: Report covers individual Neuroblastoma Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neuroblastoma Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Neuroblastoma Treatment. It assesses the current state, advancements, and potential future developments in Neuroblastoma Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neuroblastoma Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Neuroblastoma Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Neuroblastoma Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neuroblastoma Treatment, with revenue, gross margin and global market share of Neuroblastoma Treatment from 2019 to 2024.
Chapter 3, the Neuroblastoma Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Neuroblastoma Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neuroblastoma Treatment.
Chapter 13, to describe Neuroblastoma Treatment research findings and conclusion.
Neuroblastoma treatment includes medical interventions and therapies used to manage neuroblastoma, a type of cancer that affects the sympathetic nervous system, typically occurring in young children.
The market for neuroblastoma treatment is driven by the need for effective and personalized therapies to improve survival rates and long-term outcomes for pediatric cancer patients. The market's growth is also influenced by ongoing research in neuroblastoma therapeutics and the development of targeted and immunotherapeutic approaches.
The Global Info Research report includes an overview of the development of the Neuroblastoma Treatment industry chain, the market status of Hospitals (Combination Chemotherapy, Monoclonal Antibody Therapy), Clinics (Combination Chemotherapy, Monoclonal Antibody Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neuroblastoma Treatment.
Regionally, the report analyzes the Neuroblastoma Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neuroblastoma Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Neuroblastoma Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neuroblastoma Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Combination Chemotherapy, Monoclonal Antibody Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neuroblastoma Treatment market.
Regional Analysis: The report involves examining the Neuroblastoma Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neuroblastoma Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Neuroblastoma Treatment:
Company Analysis: Report covers individual Neuroblastoma Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neuroblastoma Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Neuroblastoma Treatment. It assesses the current state, advancements, and potential future developments in Neuroblastoma Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neuroblastoma Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Neuroblastoma Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Combination Chemotherapy
- Monoclonal Antibody Therapy
- Vaccine Therapy
- Chimeric Antigen Receptor T-Cell Immunotherapy
- Oncolytic Virus Therapy
- Hospitals
- Clinics
- Others
- Seattle Children’s
- CureSearch
- Texas Children’s
- NANT
- Sino Biopharmaceutical
- Jiangsu Hengrui Medicine Co.,Ltd.
- Fosun Pharmaceutical
- Novartis
- Juno Therapeutics
- Kite Pharma
- Adaptimmune
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Neuroblastoma Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neuroblastoma Treatment, with revenue, gross margin and global market share of Neuroblastoma Treatment from 2019 to 2024.
Chapter 3, the Neuroblastoma Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Neuroblastoma Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neuroblastoma Treatment.
Chapter 13, to describe Neuroblastoma Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Neuroblastoma Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neuroblastoma Treatment by Type
1.3.1 Overview: Global Neuroblastoma Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Neuroblastoma Treatment Consumption Value Market Share by Type in 2023
1.3.3 Combination Chemotherapy
1.3.4 Monoclonal Antibody Therapy
1.3.5 Vaccine Therapy
1.3.6 Chimeric Antigen Receptor T-Cell Immunotherapy
1.3.7 Oncolytic Virus Therapy
1.4 Global Neuroblastoma Treatment Market by Application
1.4.1 Overview: Global Neuroblastoma Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Neuroblastoma Treatment Market Size & Forecast
1.6 Global Neuroblastoma Treatment Market Size and Forecast by Region
1.6.1 Global Neuroblastoma Treatment Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Neuroblastoma Treatment Market Size by Region, (2019-2030)
1.6.3 North America Neuroblastoma Treatment Market Size and Prospect (2019-2030)
1.6.4 Europe Neuroblastoma Treatment Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Neuroblastoma Treatment Market Size and Prospect (2019-2030)
1.6.6 South America Neuroblastoma Treatment Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Neuroblastoma Treatment Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Seattle Children’s
2.1.1 Seattle Children’s Details
2.1.2 Seattle Children’s Major Business
2.1.3 Seattle Children’s Neuroblastoma Treatment Product and Solutions
2.1.4 Seattle Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Seattle Children’s Recent Developments and Future Plans
2.2 CureSearch
2.2.1 CureSearch Details
2.2.2 CureSearch Major Business
2.2.3 CureSearch Neuroblastoma Treatment Product and Solutions
2.2.4 CureSearch Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CureSearch Recent Developments and Future Plans
2.3 Texas Children’s
2.3.1 Texas Children’s Details
2.3.2 Texas Children’s Major Business
2.3.3 Texas Children’s Neuroblastoma Treatment Product and Solutions
2.3.4 Texas Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Texas Children’s Recent Developments and Future Plans
2.4 NANT
2.4.1 NANT Details
2.4.2 NANT Major Business
2.4.3 NANT Neuroblastoma Treatment Product and Solutions
2.4.4 NANT Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 NANT Recent Developments and Future Plans
2.5 Sino Biopharmaceutical
2.5.1 Sino Biopharmaceutical Details
2.5.2 Sino Biopharmaceutical Major Business
2.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Product and Solutions
2.5.4 Sino Biopharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sino Biopharmaceutical Recent Developments and Future Plans
2.6 Jiangsu Hengrui Medicine Co.,Ltd.
2.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Details
2.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Major Business
2.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product and Solutions
2.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments and Future Plans
2.7 Fosun Pharmaceutical
2.7.1 Fosun Pharmaceutical Details
2.7.2 Fosun Pharmaceutical Major Business
2.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Product and Solutions
2.7.4 Fosun Pharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Fosun Pharmaceutical Recent Developments and Future Plans
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Neuroblastoma Treatment Product and Solutions
2.8.4 Novartis Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novartis Recent Developments and Future Plans
2.9 Juno Therapeutics
2.9.1 Juno Therapeutics Details
2.9.2 Juno Therapeutics Major Business
2.9.3 Juno Therapeutics Neuroblastoma Treatment Product and Solutions
2.9.4 Juno Therapeutics Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Juno Therapeutics Recent Developments and Future Plans
2.10 Kite Pharma
2.10.1 Kite Pharma Details
2.10.2 Kite Pharma Major Business
2.10.3 Kite Pharma Neuroblastoma Treatment Product and Solutions
2.10.4 Kite Pharma Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Kite Pharma Recent Developments and Future Plans
2.11 Adaptimmune
2.11.1 Adaptimmune Details
2.11.2 Adaptimmune Major Business
2.11.3 Adaptimmune Neuroblastoma Treatment Product and Solutions
2.11.4 Adaptimmune Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Adaptimmune Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neuroblastoma Treatment Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Neuroblastoma Treatment by Company Revenue
3.2.2 Top 3 Neuroblastoma Treatment Players Market Share in 2023
3.2.3 Top 6 Neuroblastoma Treatment Players Market Share in 2023
3.3 Neuroblastoma Treatment Market: Overall Company Footprint Analysis
3.3.1 Neuroblastoma Treatment Market: Region Footprint
3.3.2 Neuroblastoma Treatment Market: Company Product Type Footprint
3.3.3 Neuroblastoma Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neuroblastoma Treatment Consumption Value and Market Share by Type (2019-2024)
4.2 Global Neuroblastoma Treatment Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2024)
5.2 Global Neuroblastoma Treatment Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Neuroblastoma Treatment Consumption Value by Type (2019-2030)
6.2 North America Neuroblastoma Treatment Consumption Value by Application (2019-2030)
6.3 North America Neuroblastoma Treatment Market Size by Country
6.3.1 North America Neuroblastoma Treatment Consumption Value by Country (2019-2030)
6.3.2 United States Neuroblastoma Treatment Market Size and Forecast (2019-2030)
6.3.3 Canada Neuroblastoma Treatment Market Size and Forecast (2019-2030)
6.3.4 Mexico Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Neuroblastoma Treatment Consumption Value by Type (2019-2030)
7.2 Europe Neuroblastoma Treatment Consumption Value by Application (2019-2030)
7.3 Europe Neuroblastoma Treatment Market Size by Country
7.3.1 Europe Neuroblastoma Treatment Consumption Value by Country (2019-2030)
7.3.2 Germany Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7.3.3 France Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7.3.5 Russia Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7.3.6 Italy Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neuroblastoma Treatment Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Neuroblastoma Treatment Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Neuroblastoma Treatment Market Size by Region
8.3.1 Asia-Pacific Neuroblastoma Treatment Consumption Value by Region (2019-2030)
8.3.2 China Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.3 Japan Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.4 South Korea Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.5 India Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.7 Australia Neuroblastoma Treatment Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Neuroblastoma Treatment Consumption Value by Type (2019-2030)
9.2 South America Neuroblastoma Treatment Consumption Value by Application (2019-2030)
9.3 South America Neuroblastoma Treatment Market Size by Country
9.3.1 South America Neuroblastoma Treatment Consumption Value by Country (2019-2030)
9.3.2 Brazil Neuroblastoma Treatment Market Size and Forecast (2019-2030)
9.3.3 Argentina Neuroblastoma Treatment Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neuroblastoma Treatment Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Neuroblastoma Treatment Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Neuroblastoma Treatment Market Size by Country
10.3.1 Middle East & Africa Neuroblastoma Treatment Consumption Value by Country (2019-2030)
10.3.2 Turkey Neuroblastoma Treatment Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Neuroblastoma Treatment Market Size and Forecast (2019-2030)
10.3.4 UAE Neuroblastoma Treatment Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Neuroblastoma Treatment Market Drivers
11.2 Neuroblastoma Treatment Market Restraints
11.3 Neuroblastoma Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Neuroblastoma Treatment Industry Chain
12.2 Neuroblastoma Treatment Upstream Analysis
12.3 Neuroblastoma Treatment Midstream Analysis
12.4 Neuroblastoma Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Neuroblastoma Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neuroblastoma Treatment by Type
1.3.1 Overview: Global Neuroblastoma Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Neuroblastoma Treatment Consumption Value Market Share by Type in 2023
1.3.3 Combination Chemotherapy
1.3.4 Monoclonal Antibody Therapy
1.3.5 Vaccine Therapy
1.3.6 Chimeric Antigen Receptor T-Cell Immunotherapy
1.3.7 Oncolytic Virus Therapy
1.4 Global Neuroblastoma Treatment Market by Application
1.4.1 Overview: Global Neuroblastoma Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Neuroblastoma Treatment Market Size & Forecast
1.6 Global Neuroblastoma Treatment Market Size and Forecast by Region
1.6.1 Global Neuroblastoma Treatment Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Neuroblastoma Treatment Market Size by Region, (2019-2030)
1.6.3 North America Neuroblastoma Treatment Market Size and Prospect (2019-2030)
1.6.4 Europe Neuroblastoma Treatment Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Neuroblastoma Treatment Market Size and Prospect (2019-2030)
1.6.6 South America Neuroblastoma Treatment Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Neuroblastoma Treatment Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Seattle Children’s
2.1.1 Seattle Children’s Details
2.1.2 Seattle Children’s Major Business
2.1.3 Seattle Children’s Neuroblastoma Treatment Product and Solutions
2.1.4 Seattle Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Seattle Children’s Recent Developments and Future Plans
2.2 CureSearch
2.2.1 CureSearch Details
2.2.2 CureSearch Major Business
2.2.3 CureSearch Neuroblastoma Treatment Product and Solutions
2.2.4 CureSearch Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CureSearch Recent Developments and Future Plans
2.3 Texas Children’s
2.3.1 Texas Children’s Details
2.3.2 Texas Children’s Major Business
2.3.3 Texas Children’s Neuroblastoma Treatment Product and Solutions
2.3.4 Texas Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Texas Children’s Recent Developments and Future Plans
2.4 NANT
2.4.1 NANT Details
2.4.2 NANT Major Business
2.4.3 NANT Neuroblastoma Treatment Product and Solutions
2.4.4 NANT Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 NANT Recent Developments and Future Plans
2.5 Sino Biopharmaceutical
2.5.1 Sino Biopharmaceutical Details
2.5.2 Sino Biopharmaceutical Major Business
2.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Product and Solutions
2.5.4 Sino Biopharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sino Biopharmaceutical Recent Developments and Future Plans
2.6 Jiangsu Hengrui Medicine Co.,Ltd.
2.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Details
2.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Major Business
2.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product and Solutions
2.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments and Future Plans
2.7 Fosun Pharmaceutical
2.7.1 Fosun Pharmaceutical Details
2.7.2 Fosun Pharmaceutical Major Business
2.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Product and Solutions
2.7.4 Fosun Pharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Fosun Pharmaceutical Recent Developments and Future Plans
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Neuroblastoma Treatment Product and Solutions
2.8.4 Novartis Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novartis Recent Developments and Future Plans
2.9 Juno Therapeutics
2.9.1 Juno Therapeutics Details
2.9.2 Juno Therapeutics Major Business
2.9.3 Juno Therapeutics Neuroblastoma Treatment Product and Solutions
2.9.4 Juno Therapeutics Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Juno Therapeutics Recent Developments and Future Plans
2.10 Kite Pharma
2.10.1 Kite Pharma Details
2.10.2 Kite Pharma Major Business
2.10.3 Kite Pharma Neuroblastoma Treatment Product and Solutions
2.10.4 Kite Pharma Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Kite Pharma Recent Developments and Future Plans
2.11 Adaptimmune
2.11.1 Adaptimmune Details
2.11.2 Adaptimmune Major Business
2.11.3 Adaptimmune Neuroblastoma Treatment Product and Solutions
2.11.4 Adaptimmune Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Adaptimmune Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neuroblastoma Treatment Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Neuroblastoma Treatment by Company Revenue
3.2.2 Top 3 Neuroblastoma Treatment Players Market Share in 2023
3.2.3 Top 6 Neuroblastoma Treatment Players Market Share in 2023
3.3 Neuroblastoma Treatment Market: Overall Company Footprint Analysis
3.3.1 Neuroblastoma Treatment Market: Region Footprint
3.3.2 Neuroblastoma Treatment Market: Company Product Type Footprint
3.3.3 Neuroblastoma Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neuroblastoma Treatment Consumption Value and Market Share by Type (2019-2024)
4.2 Global Neuroblastoma Treatment Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2024)
5.2 Global Neuroblastoma Treatment Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Neuroblastoma Treatment Consumption Value by Type (2019-2030)
6.2 North America Neuroblastoma Treatment Consumption Value by Application (2019-2030)
6.3 North America Neuroblastoma Treatment Market Size by Country
6.3.1 North America Neuroblastoma Treatment Consumption Value by Country (2019-2030)
6.3.2 United States Neuroblastoma Treatment Market Size and Forecast (2019-2030)
6.3.3 Canada Neuroblastoma Treatment Market Size and Forecast (2019-2030)
6.3.4 Mexico Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Neuroblastoma Treatment Consumption Value by Type (2019-2030)
7.2 Europe Neuroblastoma Treatment Consumption Value by Application (2019-2030)
7.3 Europe Neuroblastoma Treatment Market Size by Country
7.3.1 Europe Neuroblastoma Treatment Consumption Value by Country (2019-2030)
7.3.2 Germany Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7.3.3 France Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7.3.5 Russia Neuroblastoma Treatment Market Size and Forecast (2019-2030)
7.3.6 Italy Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neuroblastoma Treatment Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Neuroblastoma Treatment Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Neuroblastoma Treatment Market Size by Region
8.3.1 Asia-Pacific Neuroblastoma Treatment Consumption Value by Region (2019-2030)
8.3.2 China Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.3 Japan Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.4 South Korea Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.5 India Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Neuroblastoma Treatment Market Size and Forecast (2019-2030)
8.3.7 Australia Neuroblastoma Treatment Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Neuroblastoma Treatment Consumption Value by Type (2019-2030)
9.2 South America Neuroblastoma Treatment Consumption Value by Application (2019-2030)
9.3 South America Neuroblastoma Treatment Market Size by Country
9.3.1 South America Neuroblastoma Treatment Consumption Value by Country (2019-2030)
9.3.2 Brazil Neuroblastoma Treatment Market Size and Forecast (2019-2030)
9.3.3 Argentina Neuroblastoma Treatment Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neuroblastoma Treatment Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Neuroblastoma Treatment Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Neuroblastoma Treatment Market Size by Country
10.3.1 Middle East & Africa Neuroblastoma Treatment Consumption Value by Country (2019-2030)
10.3.2 Turkey Neuroblastoma Treatment Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Neuroblastoma Treatment Market Size and Forecast (2019-2030)
10.3.4 UAE Neuroblastoma Treatment Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Neuroblastoma Treatment Market Drivers
11.2 Neuroblastoma Treatment Market Restraints
11.3 Neuroblastoma Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Neuroblastoma Treatment Industry Chain
12.2 Neuroblastoma Treatment Upstream Analysis
12.3 Neuroblastoma Treatment Midstream Analysis
12.4 Neuroblastoma Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Neuroblastoma Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Neuroblastoma Treatment Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Neuroblastoma Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Neuroblastoma Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Seattle Children’s Company Information, Head Office, and Major Competitors
Table 6. Seattle Children’s Major Business
Table 7. Seattle Children’s Neuroblastoma Treatment Product and Solutions
Table 8. Seattle Children’s Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Seattle Children’s Recent Developments and Future Plans
Table 10. CureSearch Company Information, Head Office, and Major Competitors
Table 11. CureSearch Major Business
Table 12. CureSearch Neuroblastoma Treatment Product and Solutions
Table 13. CureSearch Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. CureSearch Recent Developments and Future Plans
Table 15. Texas Children’s Company Information, Head Office, and Major Competitors
Table 16. Texas Children’s Major Business
Table 17. Texas Children’s Neuroblastoma Treatment Product and Solutions
Table 18. Texas Children’s Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Texas Children’s Recent Developments and Future Plans
Table 20. NANT Company Information, Head Office, and Major Competitors
Table 21. NANT Major Business
Table 22. NANT Neuroblastoma Treatment Product and Solutions
Table 23. NANT Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. NANT Recent Developments and Future Plans
Table 25. Sino Biopharmaceutical Company Information, Head Office, and Major Competitors
Table 26. Sino Biopharmaceutical Major Business
Table 27. Sino Biopharmaceutical Neuroblastoma Treatment Product and Solutions
Table 28. Sino Biopharmaceutical Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sino Biopharmaceutical Recent Developments and Future Plans
Table 30. Jiangsu Hengrui Medicine Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 31. Jiangsu Hengrui Medicine Co.,Ltd. Major Business
Table 32. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product and Solutions
Table 33. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments and Future Plans
Table 35. Fosun Pharmaceutical Company Information, Head Office, and Major Competitors
Table 36. Fosun Pharmaceutical Major Business
Table 37. Fosun Pharmaceutical Neuroblastoma Treatment Product and Solutions
Table 38. Fosun Pharmaceutical Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Fosun Pharmaceutical Recent Developments and Future Plans
Table 40. Novartis Company Information, Head Office, and Major Competitors
Table 41. Novartis Major Business
Table 42. Novartis Neuroblastoma Treatment Product and Solutions
Table 43. Novartis Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Novartis Recent Developments and Future Plans
Table 45. Juno Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Juno Therapeutics Major Business
Table 47. Juno Therapeutics Neuroblastoma Treatment Product and Solutions
Table 48. Juno Therapeutics Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Juno Therapeutics Recent Developments and Future Plans
Table 50. Kite Pharma Company Information, Head Office, and Major Competitors
Table 51. Kite Pharma Major Business
Table 52. Kite Pharma Neuroblastoma Treatment Product and Solutions
Table 53. Kite Pharma Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Kite Pharma Recent Developments and Future Plans
Table 55. Adaptimmune Company Information, Head Office, and Major Competitors
Table 56. Adaptimmune Major Business
Table 57. Adaptimmune Neuroblastoma Treatment Product and Solutions
Table 58. Adaptimmune Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Adaptimmune Recent Developments and Future Plans
Table 60. Global Neuroblastoma Treatment Revenue (USD Million) by Players (2019-2024)
Table 61. Global Neuroblastoma Treatment Revenue Share by Players (2019-2024)
Table 62. Breakdown of Neuroblastoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Neuroblastoma Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Neuroblastoma Treatment Players
Table 65. Neuroblastoma Treatment Market: Company Product Type Footprint
Table 66. Neuroblastoma Treatment Market: Company Product Application Footprint
Table 67. Neuroblastoma Treatment New Market Entrants and Barriers to Market Entry
Table 68. Neuroblastoma Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Neuroblastoma Treatment Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Neuroblastoma Treatment Consumption Value Share by Type (2019-2024)
Table 71. Global Neuroblastoma Treatment Consumption Value Forecast by Type (2025-2030)
Table 72. Global Neuroblastoma Treatment Consumption Value by Application (2019-2024)
Table 73. Global Neuroblastoma Treatment Consumption Value Forecast by Application (2025-2030)
Table 74. North America Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Neuroblastoma Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Neuroblastoma Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Neuroblastoma Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Neuroblastoma Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Neuroblastoma Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Neuroblastoma Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Neuroblastoma Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Neuroblastoma Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Neuroblastoma Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Neuroblastoma Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Neuroblastoma Treatment Raw Material
Table 105. Key Suppliers of Neuroblastoma Treatment Raw Materials
Table 1. Global Neuroblastoma Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Neuroblastoma Treatment Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Neuroblastoma Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Neuroblastoma Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Seattle Children’s Company Information, Head Office, and Major Competitors
Table 6. Seattle Children’s Major Business
Table 7. Seattle Children’s Neuroblastoma Treatment Product and Solutions
Table 8. Seattle Children’s Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Seattle Children’s Recent Developments and Future Plans
Table 10. CureSearch Company Information, Head Office, and Major Competitors
Table 11. CureSearch Major Business
Table 12. CureSearch Neuroblastoma Treatment Product and Solutions
Table 13. CureSearch Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. CureSearch Recent Developments and Future Plans
Table 15. Texas Children’s Company Information, Head Office, and Major Competitors
Table 16. Texas Children’s Major Business
Table 17. Texas Children’s Neuroblastoma Treatment Product and Solutions
Table 18. Texas Children’s Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Texas Children’s Recent Developments and Future Plans
Table 20. NANT Company Information, Head Office, and Major Competitors
Table 21. NANT Major Business
Table 22. NANT Neuroblastoma Treatment Product and Solutions
Table 23. NANT Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. NANT Recent Developments and Future Plans
Table 25. Sino Biopharmaceutical Company Information, Head Office, and Major Competitors
Table 26. Sino Biopharmaceutical Major Business
Table 27. Sino Biopharmaceutical Neuroblastoma Treatment Product and Solutions
Table 28. Sino Biopharmaceutical Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sino Biopharmaceutical Recent Developments and Future Plans
Table 30. Jiangsu Hengrui Medicine Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 31. Jiangsu Hengrui Medicine Co.,Ltd. Major Business
Table 32. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product and Solutions
Table 33. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments and Future Plans
Table 35. Fosun Pharmaceutical Company Information, Head Office, and Major Competitors
Table 36. Fosun Pharmaceutical Major Business
Table 37. Fosun Pharmaceutical Neuroblastoma Treatment Product and Solutions
Table 38. Fosun Pharmaceutical Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Fosun Pharmaceutical Recent Developments and Future Plans
Table 40. Novartis Company Information, Head Office, and Major Competitors
Table 41. Novartis Major Business
Table 42. Novartis Neuroblastoma Treatment Product and Solutions
Table 43. Novartis Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Novartis Recent Developments and Future Plans
Table 45. Juno Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Juno Therapeutics Major Business
Table 47. Juno Therapeutics Neuroblastoma Treatment Product and Solutions
Table 48. Juno Therapeutics Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Juno Therapeutics Recent Developments and Future Plans
Table 50. Kite Pharma Company Information, Head Office, and Major Competitors
Table 51. Kite Pharma Major Business
Table 52. Kite Pharma Neuroblastoma Treatment Product and Solutions
Table 53. Kite Pharma Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Kite Pharma Recent Developments and Future Plans
Table 55. Adaptimmune Company Information, Head Office, and Major Competitors
Table 56. Adaptimmune Major Business
Table 57. Adaptimmune Neuroblastoma Treatment Product and Solutions
Table 58. Adaptimmune Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Adaptimmune Recent Developments and Future Plans
Table 60. Global Neuroblastoma Treatment Revenue (USD Million) by Players (2019-2024)
Table 61. Global Neuroblastoma Treatment Revenue Share by Players (2019-2024)
Table 62. Breakdown of Neuroblastoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Neuroblastoma Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Neuroblastoma Treatment Players
Table 65. Neuroblastoma Treatment Market: Company Product Type Footprint
Table 66. Neuroblastoma Treatment Market: Company Product Application Footprint
Table 67. Neuroblastoma Treatment New Market Entrants and Barriers to Market Entry
Table 68. Neuroblastoma Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Neuroblastoma Treatment Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Neuroblastoma Treatment Consumption Value Share by Type (2019-2024)
Table 71. Global Neuroblastoma Treatment Consumption Value Forecast by Type (2025-2030)
Table 72. Global Neuroblastoma Treatment Consumption Value by Application (2019-2024)
Table 73. Global Neuroblastoma Treatment Consumption Value Forecast by Application (2025-2030)
Table 74. North America Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Neuroblastoma Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Neuroblastoma Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Neuroblastoma Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Neuroblastoma Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Neuroblastoma Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Neuroblastoma Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Neuroblastoma Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Neuroblastoma Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Neuroblastoma Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Neuroblastoma Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Neuroblastoma Treatment Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Neuroblastoma Treatment Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Neuroblastoma Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Neuroblastoma Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Neuroblastoma Treatment Raw Material
Table 105. Key Suppliers of Neuroblastoma Treatment Raw Materials
LIST OF FIGURES
Figure 1. Neuroblastoma Treatment Picture
Figure 2. Global Neuroblastoma Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Neuroblastoma Treatment Consumption Value Market Share by Type in 2023
Figure 4. Combination Chemotherapy
Figure 5. Monoclonal Antibody Therapy
Figure 6. Vaccine Therapy
Figure 7. Chimeric Antigen Receptor T-Cell Immunotherapy
Figure 8. Oncolytic Virus Therapy
Figure 9. Global Neuroblastoma Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Neuroblastoma Treatment Consumption Value Market Share by Application in 2023
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Others Picture
Figure 14. Global Neuroblastoma Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Neuroblastoma Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Neuroblastoma Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Neuroblastoma Treatment Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Neuroblastoma Treatment Consumption Value Market Share by Region in 2023
Figure 19. North America Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Neuroblastoma Treatment Revenue Share by Players in 2023
Figure 25. Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Neuroblastoma Treatment Market Share in 2023
Figure 27. Global Top 6 Players Neuroblastoma Treatment Market Share in 2023
Figure 28. Global Neuroblastoma Treatment Consumption Value Share by Type (2019-2024)
Figure 29. Global Neuroblastoma Treatment Market Share Forecast by Type (2025-2030)
Figure 30. Global Neuroblastoma Treatment Consumption Value Share by Application (2019-2024)
Figure 31. Global Neuroblastoma Treatment Market Share Forecast by Application (2025-2030)
Figure 32. North America Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Neuroblastoma Treatment Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Neuroblastoma Treatment Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 42. France Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Neuroblastoma Treatment Consumption Value Market Share by Region (2019-2030)
Figure 49. China Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 52. India Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Neuroblastoma Treatment Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Neuroblastoma Treatment Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 66. Neuroblastoma Treatment Market Drivers
Figure 67. Neuroblastoma Treatment Market Restraints
Figure 68. Neuroblastoma Treatment Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Neuroblastoma Treatment in 2023
Figure 71. Manufacturing Process Analysis of Neuroblastoma Treatment
Figure 72. Neuroblastoma Treatment Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Neuroblastoma Treatment Picture
Figure 2. Global Neuroblastoma Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Neuroblastoma Treatment Consumption Value Market Share by Type in 2023
Figure 4. Combination Chemotherapy
Figure 5. Monoclonal Antibody Therapy
Figure 6. Vaccine Therapy
Figure 7. Chimeric Antigen Receptor T-Cell Immunotherapy
Figure 8. Oncolytic Virus Therapy
Figure 9. Global Neuroblastoma Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Neuroblastoma Treatment Consumption Value Market Share by Application in 2023
Figure 11. Hospitals Picture
Figure 12. Clinics Picture
Figure 13. Others Picture
Figure 14. Global Neuroblastoma Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Neuroblastoma Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Neuroblastoma Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Neuroblastoma Treatment Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Neuroblastoma Treatment Consumption Value Market Share by Region in 2023
Figure 19. North America Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Neuroblastoma Treatment Revenue Share by Players in 2023
Figure 25. Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Neuroblastoma Treatment Market Share in 2023
Figure 27. Global Top 6 Players Neuroblastoma Treatment Market Share in 2023
Figure 28. Global Neuroblastoma Treatment Consumption Value Share by Type (2019-2024)
Figure 29. Global Neuroblastoma Treatment Market Share Forecast by Type (2025-2030)
Figure 30. Global Neuroblastoma Treatment Consumption Value Share by Application (2019-2024)
Figure 31. Global Neuroblastoma Treatment Market Share Forecast by Application (2025-2030)
Figure 32. North America Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Neuroblastoma Treatment Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Neuroblastoma Treatment Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 42. France Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Neuroblastoma Treatment Consumption Value Market Share by Region (2019-2030)
Figure 49. China Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 52. India Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Neuroblastoma Treatment Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Neuroblastoma Treatment Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Neuroblastoma Treatment Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Neuroblastoma Treatment Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Neuroblastoma Treatment Consumption Value (2019-2030) & (USD Million)
Figure 66. Neuroblastoma Treatment Market Drivers
Figure 67. Neuroblastoma Treatment Market Restraints
Figure 68. Neuroblastoma Treatment Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Neuroblastoma Treatment in 2023
Figure 71. Manufacturing Process Analysis of Neuroblastoma Treatment
Figure 72. Neuroblastoma Treatment Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
